Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Meng Lin, Xiaolong Wu, Lei Zhang, Ling Li, Xinhua Wang, Xiaorui Fu, Zhenchang Sun, Xudong Zhang, Linan Zhu, Hui Yu, Yu Chang, Feifei Nan, Jiaqin Yan, Zhiyuan Zhou, Cunzhen Shi, Mingzhi Zhang & Xin Li. (2023) Fotemustine, etoposide, cytarabine, and cyclophosphamide (FEAC) conditioning regimen for autologous stem cell transplantation in lymphoma. Leukemia & Lymphoma 64:3, pages 605-612.
Read now
Read now
Mojtaba Akhtari, Vijaya Raj Bhatt, Pavan Kumar Tandra, Jairam Krishnamurthy, Heidi Horstman, Amy Dreessen, Pei Xian Chen & James O Armitage. (2013) Therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplantation in lymphoma patients. Cancer Biology & Therapy 14:12, pages 1077-1088.
Read now
Read now
Yuanlin Xu, Huaqing Wang, Shiyong Zhou, Man Yu, Xianhuo Wang, Kai Fu, Zhengzi Qian, Huilai Zhang, Lihua Qiu, Xianming Liu & Ping Wang. (2013) Risk of second malignant neoplasms after cyclophosphamide-based chemotherapy with or without radiotherapy for non-Hodgkin lymphoma. Leukemia & Lymphoma 54:7, pages 1396-1404.
Read now
Read now
Articles from other publishers (18)
Melanie Powis, Saidah Hack, Rouhi Fazelzad, David Hodgson & Vishal Kukreti. (2023) Survivorship care for patients curatively treated for Hodgkin’s and non-Hodgkin’s lymphoma: a scoping review. Journal of Cancer Survivorship.
Crossref
Crossref
Lydia L. Chevalier, Alexis Michaud, Heike I. M. Mahler, Elizabeth Fine & Christopher J. Recklitis. (2023) Evaluating SunSmart: a brief educational intervention promoting sun protection in young adult cancer survivors. Journal of Cancer Survivorship.
Crossref
Crossref
Trine Trab, Joachim Baech, Lasse Hjort Jakobsen, Simon Husby, Marianne Tang Severinsen, Sandra Eloranta, Jette S Gørløv, Judit M Jørgensen, Sif Gudbrandsdottir, Thomas Stauffer Larsen, Peter Brown, Kirsten Grønbæk, Karin E Smedby & Tarec C El-Galaly. (2023) Second primary malignancies in patients with lymphoma in Denmark after high-dose chemotherapy and autologous haematopoietic stem-cell transplantation: a population-based, retrospective cohort study. The Lancet Haematology.
Crossref
Crossref
Montserrat Miret, Amanda Anderson, Pooja Hindocha, Lorena Cirneanu, Christina Lymperopoulou, Emanuil Markov, William Kizito & Ferdinando Emanuele Vegni. (2023) Incidence of second primary malignancies in relapsed/refractory B-cell non-Hodgkin’s lymphoma patients in England. Leukemia Research 127, pages 107042.
Crossref
Crossref
Tracy Lackraj, Sharon Ben Barouch, Jessie J. F. Medeiros, Stephanie Pedersen, Arnavaz Danesh, Mehran Bakhtiari, Michael Hong, Kit Tong, Jesse Joynt, Andrea Arruda, Mark D. Minden, John Kuruvilla, Sita Bhella, Vishal Kukreti, Michael Crump, Anca Prica, Christine Chen, Yangqing Deng, Wei Xu, Trevor J. Pugh, Armand Keating, John E. Dick, Sagi Abelson & Robert Kridel. (2022) Clinical significance of clonal hematopoiesis in the setting of autologous stem cell transplantation for lymphoma. American Journal of Hematology 97:12, pages 1538-1547.
Crossref
Crossref
Priyanka A. Pophali, Melissa C. Larson, Cristine Allmer, Umar Farooq, Brian K. Link, Matthew J. Maurer, James R. Cerhan & Carrie A. Thompson. (2020) Compliance with cancer screening and influenza vaccination guidelines in non-Hodgkin lymphoma survivors. Journal of Cancer Survivorship 14:3, pages 316-321.
Crossref
Crossref
Ivetta Danylesko & Avichai Shimoni. (2018) Second Malignancies after Hematopoietic Stem Cell Transplantation. Current Treatment Options in Oncology 19:2.
Crossref
Crossref
Mayumi Tsukagoshi, Saiko Kurosawa, Wataru Munakata, Shinichi Makita, Suguru Fukuhara, Tatsuya Suzuki, Dai Maruyama, Yukio Kobayashi, Ayako Mori, Yuka Okamura, Masako Ikeda, Tomoko Matsuura, Yoshihiro Inamoto, Sung-Won Kim, Koji Izutsu, Kensei Tobinai & Takahiro Fukuda. (2018) Cross-Sectional Patient Survey on the Need for a Long-Term Follow-up Program after Autologous Hematopoietic Cell Transplantation自家造血幹細胞移植後の晩期合併症と長期フォローアップ外来に関する単施設の横断的調査. Journal of Hematopoietic Cell Transplantation 7:4, pages 132-137.
Crossref
Crossref
Knut B. Smeland, Cecilie E. Kiserud, Grete F. Lauritzsen, Anne K. Blystad, Unn-Merete Fagerli, Ragnhild S. Falk, Øystein Fluge, Alexander Fosså, Arne Kolstad, Jon H. Loge, Martin Maisenhölder, Bjørn Østenstad, Stein Kvaløy & Harald Holte. (2016) A national study on conditional survival, excess mortality and second cancer after high dose therapy with autologous stem cell transplantation for non-Hodgkin lymphoma. British Journal of Haematology 173:3, pages 432-443.
Crossref
Crossref
J. Wang, J. S. Pulido, B. P. O'Neill & P. B. Johnston. (2014) Second malignancies in patients with primary central nervous system lymphoma. Neuro-Oncology 17:1, pages 129-135.
Crossref
Crossref
Simone Oerlemans, Floortje Mols, Marten R. Nijziel, Wobbe P. Zijlstra, Jan Willem W. Coebergh & Lonneke V. van de Poll-Franse. (2014) The course of anxiety and depression for patients with Hodgkin’s lymphoma or diffuse large B cell lymphoma: a longitudinal study of the PROFILES registry. Journal of Cancer Survivorship 8:4, pages 555-564.
Crossref
Crossref
I A Bilmon, L J Ashton, R E Le Marsney, A J Dodds, T A O'Brien, L Wilcox, I Nivison-Smith, B Daniels, C M Vajdic, L Ashton, R Le Marsney, A Dodds, J Tan, I Bilmon, L Wilcox, I Nivison-Smith, D Aarons, S Tran, C Vajdic, J Gibson, A Johnston, M Greenwood, M Forbes, M Hertzberg, G Huang, A Spencer, J Muirhead, J Szer, K Mason, I Lewis, C To, S Durrant, R Western, P Cannell, S Buffery, T O'Brien, C Oswald, A Nelson, P Shaw, L Pearson, K Tiedemann, M Scoyne, C Fraser, J Seljak, C Cole, K Rowland, H Gough, H Tapp, N Green, A Moa, J McRae, M Jenkins, J Hicks & K Chaplin. (2014) Second cancer risk in adults receiving autologous haematopoietic SCT for cancer: a population-based cohort study. Bone Marrow Transplantation 49:5, pages 691-698.
Crossref
Crossref
Sairah Ahmed & Yago Nieto. 2013. Blood and Marrow Transplantation Long‐Term Management. Blood and Marrow Transplantation Long‐Term Management
31
42
.
Marco Capobianco, Y. Motuzova, J. Frau, E. Cocco, E. Mamusa, M. G. Marrosu & A. Bertolotto. (2011) Natalizumab in aggressive multiple sclerosis after haematopoietic stem cell transplantation. Neurological Sciences 33:4, pages 863-867.
Crossref
Crossref
Eric K. Zwemer, Heike I. M. Mahler, Andrew E. Werchniak & Christopher J. Recklitis. (2011) Sun exposure in young adult cancer survivors on and off the beach: results from Project REACH. Journal of Cancer Survivorship 6:1, pages 63-71.
Crossref
Crossref
Ananth Shankar, Maria Visaduraki, Janis Hayward, Bruce Morland, Keith McCarthy & Martin Hewitt. (2012) Clinical outcome in children and adolescents with Hodgkin lymphoma after treatment with chemotherapy alone ? The results of the United Kingdom HD3 national cohort trial. European Journal of Cancer 48:1, pages 108-113.
Crossref
Crossref
Jeong Eun Kim, Dae Ho Lee, Changhoon Yoo, Shin Kim, Sang-We Kim, Jung-Shin Lee, Chan Jeong Park, Jooryung Huh & Cheolwon Suh. (2011) BEAM or BuCyE high-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma patients: A single center comparative analysis of efficacy and toxicity. Leukemia Research 35:2, pages 183-187.
Crossref
Crossref
Marie-Sarah Dilhuydy, Thierry Lamy, Charles Foussard, Remy Gressin, Philippe Casassus, Eric Deconninck, Christine Le Maignan, Diane Damotte & Noel Milpied. (2010) Front-line High-Dose Chemotherapy with Rituximab Showed Excellent Long-Term Survival in Adults with Aggressive Large B-Cell Lymphoma: Final Results of a Phase II GOELAMS Study. Biology of Blood and Marrow Transplantation 16:5, pages 672-677.
Crossref
Crossref